ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,378Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 794

$3.62M Total Retail Price of All Prescriptions

Rank: 5 out of 794

592 Patients Receiving at Least One Drug in Part D
68% Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 592 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

4% of this provider’s 592 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$432 was the average price of a prescription from this provider, compared to $254 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
CARBIDOPA-LEVODOPA 368 326 64 1 1
PRAMIPEXOLE DIHYDROCHLORIDE 324 188 76 2 11
CLONAZEPAM 297 231 59 B 3 10
NAMENDA 244 205 39 4 5
AZILECT 241 222 39 5 12
GABAPENTIN 223 162 53 6 3
ROPINIROLE HCL 213 133 41 7 13
EXELON 211 186 45 8 14
CYMBALTA 191 111 34 9 24
AMANTADINE 189 168 35 10 25
LEVETIRACETAM 187 94 33 11 4
COPAXONE 187 53 21 11 31
DONEPEZIL HCL 164 159* 31 13 2
TRAZODONE HCL 154 116 46 14 37
CARBIDOPA-LEVODOPA ER 154 105 26 14 7
LAMOTRIGINE 147 71 22 16 8
BACLOFEN 137 13 26 17 20
ZONISAMIDE 126 92 24 18 41
TIZANIDINE HCL 98 28 25 19 61
NUVIGIL 97 64 25 20 130
FLUTICASONE PROPIONATE 97 62 42 20 170
ZOLPIDEM TARTRATE 93 59 25 22 32
MIRTAZAPINE 90 77 24 23 44
OXCARBAZEPINE 89 32 14 24 38
LEVOTHYROXINE SODIUM 84 55 16 25 84
TOPIRAMATE 84 63 14 25 6
CLOPIDOGREL 83 78* 17 27 17
DICLOFENAC SODIUM 73 34 19 28 101
DEXILANT 73 46 17 28 135
LYRICA 70 40 14 30 18
AMPYRA 69 <11 12 31 83
VESICARE 68 48 12 32 145
PYRIDOSTIGMINE BROMIDE 65 60* 12 33 97
DIVALPROEX SODIUM ER 63 58* 15 34 34
PRIMIDONE 62 <11 <11 35 16
OMEPRAZOLE 60 24 15 36 74
AUBAGIO 60 <11 <11 36 106
DIVALPROEX SODIUM 58 <11 <11 38 26
VIMPAT 58 <11 <11 38 33
GILENYA 56 <11 <11 40 79
HYDROCODONE-ACETAMINOPHEN 55 15 13 S3 41 9
ESCITALOPRAM OXALATE 54 41 12 42 21
METHOCARBAMOL 54 24 15 R 42 139
MELOXICAM 52 47* 14 44 40
TEMAZEPAM 51 32 14 B 45 90
QUETIAPINE FUMARATE 51 32 12 A 45 15
CELEBREX 50 36 13 47 76
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.